1. Introduction

   • M. J. Kendall

   EditorialNotes Pages: S1 - S1

2. Design of a new multiple-unit controlled-release formulation of metoprolol — Metoprolol CR

   • A. Sandberg
   • G. Ragnarsson
   • J. Sjögren

   OriginalPaper Pages: S3 - S7

3. Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: A comparison with conventional tablets

   • A. Sandberg
   • I. Blomqvist
   • P. Lundborg

   OriginalPaper Pages: S9 - S14

4. Pharmacokinetic and pharmacodynamic comparison of a new controlled-release formulation of metoprolol with a traditional slow-release formulation

   • B. Oosterhuis
   • J. H. G. Jonkman
   • F. A. Kerkhof

   OriginalPaper Pages: S15 - S18

5. Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: A comparison with atenolol

   • I. Blomqvist
   • G. Westergren
   • P. Lundborg

   OriginalPaper Pages: S19 - S24

6. Controlled-release metoprolol compared with atenolol in asthmatic patients: Interaction with terbutaline

   • C. -G. Löfdahl
   • C. Dahlöf
   • N. Svedmyr

   OriginalPaper Pages: S25 - S32

7. Effect of controlled-release metoprolol on blood pressure and exercise heart rate in hypertension: A comparison with conventional tablets

   • L. Rydén
   • B. E. Kristensson
   • G. Westergren

   OriginalPaper Pages: S33 - S37

8. Efficacy and tolerability of a new controlled-release formulation of metoprolol: A comparison with conventional metoprolol tablets in mild to moderate hypertension

   • J. J. R. Houtzagers
   • J. G. Smilde
   • G. Westergren

   OriginalPaper Pages: S39 - S44

9. The antianginal efficacy and tolerability of controlled-release metoprolol once daily: A comparison with conventional metoprolol tablets twice daily

   • K. Egstrup
   • T. Gundersen
   • B. Lundgren

   OriginalPaper Pages: S45 - S49